Table 3 One-year outcomes of patient groups according to the clustering method (k = 3/test set).
Cluster 0 | Cluster 1 | Cluster 2 | P-value | |
|---|---|---|---|---|
(A) K-prototype | ||||
N | 949 | 168 | 413 | |
Primary outcome | 136 (14.3%) | 16 (9.5%) | 49 (11.9%) | 0.158 |
Stroke | 26 (2.7%) | 3 (1.8%) | 14 (3.4%) | 0.557 |
MI | 0 (0.0%) | 0 (0.0%) | 2 (0.5%) | 0.067 |
All-cause mortality | 117 (12.3%) | 14 (8.3%) | 37 (9.0%) | 0.096 |
(B) SSC-Bair | ||||
N | 164 | 952 | 414 | |
Primary outcome | 15 (9.1%) | 136 (14.3%) | 50 (12.1%) | 0.150 |
Stroke | 3 (1.8%) | 26 (2.7%) | 14 (3.4%) | 0.579 |
MI | 0 (0.0%) | 0 (0.0%) | 2 (0.5%) | 0.067 |
All-cause mortality | 13 (7.9%) | 117 (12.3%) | 38 (9.2%) | 0.100 |
(C) DLC-MMD | ||||
N | 966 | 527 | 37 | |
Primary outcome | 69 (7.1%) | 117 (22.2%) | 15 (40.5%) | < 0.001 |
Stroke | 20 (2.1%) | 23 (4.4%) | 0 (0.0%) | 0.022 |
MI | 1 (0.1%) | 1 (0.2%) | 0 (0.0%) | 0.885 |
All-cause mortality | 52 (5.4%) | 101 (19.2%) | 15 (40.5%) | < 0.001 |
(D) DLC-Kuiper | ||||
N | 156 | 677 | 697 | |
Primary outcome | 65 (41.7%) | 91 (13.4%) | 45 (6.5%) | < 0.001 |
Stroke | 8 (5.1%) | 23 (3.4%) | 12 (1.7%) | 0.031 |
MI | 0 (0.0%) | 2 (0.3%) | 0 (0.0%) | 0.283 |
All-cause mortality | 63 (40.4%) | 69 (10.2%) | 36 (5.2%) | < 0.001 |
